Health & Medicine Week back issues from April 2004:
Medical privacy law makes health research harder, more expensive.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- As the 1-year anniversary of the U.S. medical privacy law approaches, a new study shows the negative impact that its implementation may be having on certain kinds of health research. At the Annual Scientific Session of the American ...
Healthier milk straight from the cow.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- British scientists have found a natural way to produce healthier milk and butter. Cows fed rapeseed oil as part of their daily diet produce milk with a significantly less saturated fat. Butter made from the milk is easier to spread at ...
Deficits associated with prenatal alcohol exposure can be seen as early as infancy.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Alcohol-exposed babies respond more slowly to their environment, and take longer to calm down, according to a new study. Most of the research on arousal and attention deficits caused by prenatal alcohol exposure has been conducted with ...
One million disabled adults lack adequate help with essential needs.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- About 3.3 million adults living in the community need assistance from another person in two or more activities of daily living essential for their survival, and nearly a million of those individuals need more help than they currently receive, ...
Researchers discover memory mechanism.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Massachusetts Institute of Technology (MIT) neuroscientists have discovered a new brain mechanism controlling the formation of lasting memories. This mechanism explains how signals between neurons stimulate production of the protein building blocks ...
Impaired sense of smell increases risk for certain hazards.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Patients with an impaired or absent sense of smell are at risk for experiencing certain hazards that may have been avoided with an intact sense of smell, according to a new study. Approximately 2.7 million adults in the United States ...
FDA clears LaparoShield system for minimally invasive abdominal surgery.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Pall Corporation (PLL) announced U.S. Food and Drug Administration (FDA) clearance to market its new LaparoShield Conditioned Insufflation Gas (CIG) System. By conditioning the carbon dioxide (CO[subscript]2) gas used in laparoscopic ...
New study demonstrates the benefits of intensive statin therapy.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Results from a new study demonstrate the benefit of initiating intensive cholesterol-lowering therapy within 10 days in people hospitalized with an acute coronary syndrome. The TIMI 22 study (Pravastatin or Atorvastatin Evaluation and ...
Women with acute coronary syndrome receive less treatment than men, data shows.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- According to an analysis of more than 35,000 patients, women entering a hospital with acute coronary syndrome (ACS) were less likely than men to receive many medications that have been shown to improve clinical outcomes and save lives. ...
Lovenox effective in non-ST-elevation acute coronary syndromes, study shows.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The results of a landmark, 10,027-patient study show that Lovenox (enoxaparin sodium injection) is as effective as unfractionated heparin (UFH) in the treatment of high-risk patients with non-ST-elevation acute coronary syndromes (ACS) undergoing a ...
Cloretazine receives Fast Track designation from FDA.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Vion Pharmaceuticals, Inc., (VION) has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for Cloretazine (VNP40101M) in relapsed or refractory acute myeloid leukemia (AML). The FDA's fast track programs are ...
Endoglin is highly expressed in eyes with choroidal neovascularization.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Endoglin is highly expressed in eyes with choroidal neovascularization. "Endoglin (CD105) is a membrane protein involved in the transforming growth factor (TGF)-beta receptor signaling pathway with predominant expression by proliferating ...
Positive results announced for long-term study of Zeatin.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Senetek PLC (SNTK) announced uniformly positive results for its multi-faceted study of the effects of its patented adenine derivative Zeatin on human skin cells. The study, conducted at the University of Aarhus, Denmark, evaluated the ...
Manufacture of validation batches for allergy drug completed.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Elite Pharmaceuticals, Inc., (ELI) announced completion of the manufacture of validation batches for a once-a-day product that treats allergies and the symptoms of allergies. The product was developed for an undisclosed U.S ....
Test kit launched to check for residential indoor allergens.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- American Home Laboratories, Inc., (AHL) announced the launch of AllergenREPORT, a home test kit that screens for elevated levels of residential indoor allergens, including dust mite, cockroach, cat, and dog. Sensitivity to indoor ...
Hay fever hits New Mexico hard.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- New Mexico's hay fever season has arrived with a vengeance. "The junipers are going now," said Curtis Smith, a horticulture specialist with New Mexico State University. "They started a few weeks ago. Watching the trees I see that the ...
Alternaria stimulates a case of life-threatening asthma.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Alternaria stimulates a case of life-threatening asthma. "Acute, severe asthma attacks can be precipitated by a variety of stimuli including exposure to aeroallergens, viral respiratory infections, pollutants, and occupational chemicals ....
Clearant process-treated allografts reduce risk of infection, study shows.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Clinical findings presented at the annual meeting of the American Association of Orthopedic Surgeons showed that patients who received human tissue allograft implants that were treated with a new pathogen inactivation method - the Clearant Process ...
Chondroitin sulfate of appican interacts with neuroregulatory factors.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Chondroitin sulfate of appican, the proteoglycan form of amyloid precursor protein, produced by C6 glioma cells interacts with heparin-binding neuroregulatory factors. "Appican produced by rat C6 glioma cells, the chondroitin sulfate ...
Selective BACE-1 inhibitors synthesized.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Scientists have synthesized a series of selective beta-site amyloid precursor protein cleaving enzyme (BACE-1) inhibitors. According to a study from the United States, "An effective approach for enhancing the selectivity of beta-site ...
Synaptic frailty and vesicle trafficking in Alzheimer disease reviewed.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Researchers review synaptic frailty and clathrin-mediated synaptic vesicle trafficking in Alzheimer disease in a recent issue of Trends in Neurosciences. "Loss of synapses contributes to the progressive cognitive impairment in Alzheimer ...
LDL receptor-related protein overexpression linked to memory deficits.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Amyloid model mice overexpressing the low-density lipoprotein receptor-related protein exhibit increased soluble amyloid-beta peptide and memory deficits. "Amyloid-beta peptide (A-beta) is central to the pathogenesis of Alzheimer ...
Microglial activation facilitates A-beta plaque removal.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Microglial activation facilitates A-beta plaque removal following intracranial anti-A beta antibody administration. According to a study from the United States, "The mechanisms by which anti-A-beta antibodies clear amyloid plaques in ...
Drug shows promise against Lou Gehrig disease.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig disease, causes nerve cells in the spinal cord and brain to die, eventually leading to paralysis and death. In the April 2004 issue of Nature Medicine, Linda Greensmith and ...
Researchers find that coronary aneurysms are independent predictor of mortality.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The results of a study presented at the American College of Cardiology's 53rd Scientific Sessions in New Orleans concludes that coronary aneurysms - regardless of size - are associated with a increased risk of death over a 5-year period and should ...
Oral formulation of Fasudil improves stable angina in study patients.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Schering AG, Germany, (SHR) announced that study patients with stable angina receiving the oral formulation of fasudil showed an improvement in oxygen delivery to the heart. Fasudil, which Schering licensed from Asahi Kasei Pharma, is ...
Veins of the human female gynecological system behave like a venous pool.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Veins of the human female gynecological system behave like a venous pool. "We described the anatomy of the utero-ovarian venous system in the adult postmenopausal female cadaver using casts and the von Hagen's plastination technique. To ...
ABthrax found to be safe and well tolerated.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Human Genome Sciences, Inc., (HGSI) announced that the results of a phase I clinical trial demonstrate that ABthrax (human monoclonal antibody to Bacillus anthracis protective antigen) is safe and well tolerated in healthy volunteers, and achieved ...
Company announces new biodefense-related contract work.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Commonwealth Biotechnologies, Inc., (CBTE) (CBI), a life sciences contract research organization and biotechnology company, announced execution of two major biodefense-related contracts valued at nearly $1 million. The company expects to ...
GyrB distinguishes members of Bacillus anthracis-cereus-thuringiensis group.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The gyrB gene can be used to distinguish members of the Bacillus anthracis-cereus-thuringiensis group. "Bacillus anthracis, the causative agent of the human disease anthrax, Bacillus cereus, a food-borne pathogen capable of causing human ...
U.S. to stockpile new vaccine.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The U.S. government is planning to stockpile enough doses of an experimental new anthrax vaccine to inoculate 25 million people. Studies designed to prove whether this new vaccine is safe are still in early stages. But the government is ...
Antibiotics alter the normal bacterial flora in humans.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Bacteria that are resistant to antibiotics can live in the human intestines for at least 1 year. Professor Charlotta Edlund from the Karolinska Institute in Stockholm, Sweden, and Research Professor Pentti Huovinen from the National Public Health ...
Consumer group seeking ban on antidepressant sues U.S. government.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A consumer advocacy group sued the United States government March 15, 2004, seeking to force a ban on sales of the antidepressant Serzone. The drug can cause deadly liver failure and is linked to 20 deaths, and it's impossible to predict ...
Camels may be vector for multiresistant Salmonella.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Camels could be a vector for multiresistant strains of Salmonella. In a recent study, a "total of 714 samples consisting of feces, mesenteric lymph nodes, liver, spleen, abdominal and diaphragmatic muscles (each 119) were collected from ...
Antioxidant gene therapy protects hearing against antibiotic-mediated injury.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Antioxidant gene therapy protects hearing against antibiotic-mediated injury. According to a study from the United States, "aminoglycosides are commonly used antibiotics that often induce ototoxicity leading to permanent hair cell loss ...
A 2'-succinyl linker provides oligonucleotides new conduits for conjugation.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A 2'-succinyl linker provides oligonucleotides new conduits for conjugation. According to a study from Austria, "conjugation of ligands to antisense oligonucleotides is a promising approach for enhancing their effects. In this report, a ...
Pluronic lends a hand to cationic liposomes bearing antisense oligonucleotides.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Pluronic lends a hand to cationic liposomes bearing antisense oligonucleotides. According to a study from the Peoples Republic of China, "cationic liposomes modified by different Pluronic block copolymers were prepared. The influence of ...
Green fluorescent protein causes mitochondria to aggregate with Bcl-2.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Green fluorescent protein causes mitochondria to aggregate in the presence of the Bcl-2 family proteins. "Green fluorescent protein (GFP) has been widely used in a variety of experiments in cell biology. When cells were co-transfected ...
Early survival with the total artificial heart shows recent improvement.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Reduced infections and improved survival with the total artificial heart result from better patient management, researchers say. According to a study from Canada, "We report our experience with the total artificial heart (TAH) to ...
Cleavage of precursor enzyme causes amylase secretion by Aspergillus.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Researchers have found evidence that cleavage of the precursor enzyme by autocatalysis caused secretion of multiple amylases by Aspergillus niger. "The observation that a mutant strain of Aspergillus niger isolated for protease ...
Foradil Certihaler receives first European approval.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- SkyePharma PLC (SKYE, SKP) announced that the Swiss pharmaceutical regulatory authority has approved Foradil Certihaler (formoterol fumarate inhalation powder). Foradil Certihaler was codeveloped by SkyePharma PLC and Novartis Pharma AG ....
Hartford ranked 10th worst city in the U.S. for asthma patients.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A new report says Hartford, Connecticut, is the 10th worst metropolitan area in the United States for asthmatics. The nonprofit group Asthma and Allergy Foundation of America report is based on government statistics for total asthma ...
Kos announces strategic acquisition of Azmacort franchise.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Kos Pharmaceuticals, Inc., (KOSP) has entered into a product acquisition agreement with Aventis Pharmaceuticals Holdings, Inc., and a supply agreement with Aventis Pharmaceuticals, Inc., to acquire global rights to the Azmacort (triamcinolone ...
Study: Inhaled steroid therapy does not reduce fetal growth.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Inhaled steroid therapy by pregnant women with asthma does not lead to a restriction in fetal growth, according to a new study. In the largest sample to date examining the potential effects that inhaled steroids may have on intrauterine ...
Company reports that interleukin-1 gene variants increase risk for early CHD.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Interleukin Genetics, Inc., (ILGN) reported at the American College of Cardiology meeting that pro-inflammatory variants of the interleukin-1 (IL-1) gene cluster are associated with increased risk for early coronary heart disease (CHD). ...
LSBC enters research phase for development of atherosclerosis therapeutic.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Large Scale Biology Corp.'s (LSBC) exclusive license agreement with Cincinnati (Ohio) Children's Hospital Medical Center for the development of a drug to treat a leading cause of death in the U.S. has entered an initial development stage. ...
Medical device company announces launch of Eagle Eye IVUS imaging catheter.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Volcano Therapeutics, Inc., announced the global launch of its Eagle Eye intravascular ultrasound (IVUS) imaging catheter at the American College of Cardiology 53rd Scientific Session. The Eagle Eye IVUS catheter provides significantly ...
PhotoPoint PDT may stabilize atherosclerotic vulnerable plaque.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Miravant Medical Technologies (MRVT), a pharmaceutical development company specializing in PhotoPoint photodynamic therapy (PDT), announced preclinical data that may support the future treatment of patients with atherosclerosis and atherosclerotic ...
Study to examine obesity-associated diabetes and heart disease.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The rise in obesity, now at epidemic levels in the United States, has been matched by a rise in diabetes, a deadly combination that increases heart disease risk by two to five times. Research has shown an association between obesity, ...
Study demonstrates Metadate CD has greater effect than Concerta.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A study published in the March 2004 online issue of Pediatrics comparing the effects of two extended-release methylphenidate formulations in children with attention deficit hyperactivity disorder (ADHD) during the school day showed that once-daily ...
Public health monitoring of autism spectrum disorders is ongoing.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Public health monitoring of autism spectrum disorders is ongoing. According to researchers in the United States "Developmental disabilities (DDs) are conditions characterized by physical, cognitive, psychological, sensory, adaptive, ...
CDC removes Hong Kong from bird ban.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The U.S. Centers for Disease Control and Prevention (CDC) has removed Hong Kong from the jurisdictions included in an importation ban on birds and bird products. The decision to remove Hong Kong is based on its documented public health measures to ...
Chinese delegation visits Delaware to discuss avian influenza.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Delaware officials met March 16, 2004, with a delegation from the Chinese embassy to explain what the state has done to control an avian flu outbreak and request that China lift an import ban on American poultry as soon as possible. ...
Cardiology systems provider receives growth strategy excellence award.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Quinton Cardiology Systems has received Frost & Sullivan's Growth Strategy Excellence Award in the global cardiovascular monitoring devices market. According to Frost & Sullivan, the Growth Strategy Excellence Award is given to the ...
Bacteria manipulate Rho to enhance their survival.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Bacteria manipulate Rho to enhance their survival. According to a study from the United States, "Many features of cell behavior are regulated by Rho family GTPases, but the most profound effects of these proteins are on the actin ...
Company helps hospitals, manufacturers respond to new FDA rules.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- AmerisourceBergen Corporation (ABC), a pharmaceutical services company, said it has the broadest array of solutions to help pharmaceutical manufacturers and hospitals respond to the U.S. Food and Drug Administration's (FDA) new barcode regulations ....
Milestone payments received, first patients treated with Prolieve.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Celsion Corp. (CLN) announced that it has fulfilled the milestone obligations included in its distribution agreement with Boston Scientific Corporation, under which Boston Scientific will market Celsion's Prolieve Thermodilatation system. ...
$5.9M contract awarded for development of biowarfare technology.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Acacia Research Corporation (CBMX, ACTG) announced that its CombiMatrix Group has received a 2-year contract from the U.S. Department of Defense (DOD) that will provide $5.9 million to further the development of its microarray technology for the ...
Biosensor rapidly identifies broad-range of infectious organisms.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- RoboDesign International, Inc., has entered into an agreement with Isis Pharmaceuticals' Ibis program to design, develop, and manufacture commercial-ready, self-contained systems for the identification of infectious organisms. These ...
Student builds micro biosensor chip to move DNA molecules.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A Johns Hopkins undergraduate has constructed a new type of microchip that can move and isolate DNA and protein molecules. He believes that by linking the chip with analysis equipment, a user could identify medical ailments, monitor a patient's ...
Vitamins reduce risk for congenital anomalies other than neural tube defects.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Vitamin supplements reduce the risk for congenital anomalies other than neural tube defects. "Randomized trials, supported by many observational studies, have shown that periconceptional use of folic acid, alone or in multivitamin ...
Drinking well water is associated with bladder cancer in Argentina.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Study finds that the incidence of bladder cancer associated with arsenic in drinking water is lower than thought, but intake of well water long before the study was associated with an increased incidence. According to recent research ...
Tumor suppressor genes predict bladder cancer future.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The presence of two mutated genes in bladder cancer tumors indicates there is a high risk that the cancer will continue grow and spread, says a Baylor College of Medicine (BCM) researcher in a new report. One of the mutated proteins - ...
Optical glucose sensor holds promise for diabetics and intensive care patients.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Researchers at the University of California, Santa Cruz (UCSC), have developed a novel optical glucose sensor that could be used to provide continuous monitoring of glucose levels in diabetics and hospitalized patients. Recently ...
Positive phase Ib/II clinical trial results reported for Hemospan.
Apr 05, 2004 ... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Sangart, Inc., announced positive results from its phase Ib/II clinical trial involving Hemospan (MP4), a hemoglobin-based oxygen carrier designed to serve as an alternative for blood transfusions. The trial was conducted at the ...